CD28 and type 1 diabetes mellitus: We also evidenced that CD28 autonomous stimulation of peripheral blood CD4+ T cells from either healthy donors (HD) or type 1 diabetes (T1D) or multiple sclerosis (MS) patients promotes the production of inflammatory cytokines and chemokines related to the Th17 cell phenotype (32–34), including IL-22 (35).